Antibiotic Resistance and Genotypes of <i>Mycoplasma genitalium</i> during a Resistance-Guided Treatment Regime in a German University Hospital
The treatment of infections from the sexually transmitted pathogen <i>Mycoplasma genitalium</i> is hampered by the rapidly increasing resistance to the recommended first- (macrolides) and second-line antibiotics (quinolones). Thus, resistance-guided therapy (RGT) is key for its successfu...
Main Authors: | Roger Dumke, Petra Spornraft-Ragaller |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/10/8/962 |
Similar Items
-
Understanding the spread of de novo and transmitted macrolide-resistance in Mycoplasma genitalium
by: Dominique Cadosch, et al.
Published: (2020-04-01) -
Mycoplasma genitalium presence, resistance and epidemiology in Greenland
by: Dionne C. Gesink, et al.
Published: (2012-04-01) -
Macrolide-resistant Mycoplasma genitalium infections in Cuban patients: an underestimated health problem
by: Brian Arturo Mondeja, et al.
Published: (2018-11-01) -
Macrolide-Resistant Mycoplasma genitalium in Southeastern Region of the Netherlands, 2014–2017
by: Marta Adelantado, et al.
Published: (2019-11-01) -
Doxycycline and Sitafloxacin Combination Therapy for Treating Highly Resistant Mycoplasma genitalium
by: Duygu Durukan, et al.
Published: (2020-08-01)